Sustenon (Testosterone)

Quick links to important sections

Sustenon (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sustenon (Testosterone)

Property Description
Active Ingredient Four distinct testosterone esters (Propionate, Phenylpropionate, Isocaproate, Decanoate)
Form Oily solution for intramuscular injection
Pharmacological Class Androgen / Hormone and Endocrine Drug (ATC Code G03BA03)
General Purpose Testosterone Replacement Therapy (TRT)
Origin Synthetic/Derived preparation

What Kind of Medicine is Sustanon (Testosterone)?

Sustanon is a prescription combination product classified pharmacologically as an androgen and broadly as a hormone and endocrine drug. It is a synthetic/derived preparation primarily used as Testosterone Replacement Therapy (TRT). This drug’s fundamental therapeutic role is to replenish and sustain necessary testosterone levels in men diagnosed with a confirmed clinical deficiency of the hormone, a condition known as hypogonadism.


Composition and Unique Four-Ester Formulation

Sustanon is chemically distinct because its active ingredients consist of a precise blend of four different testosterone esters—propionate, phenylpropionate, isocaproate, and decanoate—in a single formulation. It is an oily solution for intramuscular injection, where the active compounds are typically dissolved in a base like Arachis Oil (peanut oil). This unique structure, containing esters of varying half-lives, is engineered to provide a sustained hormone delivery profile, which is a key characteristic intended to achieve consistent hormone levels. The concept of using a four-ester combination to regulate the rate of absorption and duration of action is used for therapeutic outcomes in long-term TRT.


General Therapeutic Role of the Testosterone Blend

The general purpose of this unique, blended formulation is to ensure the restoration of physiological levels of testosterone in the bloodstream with stable maintenance. Once injected, the testosterone esters undergo active hormone conversion into free, circulating testosterone, which is essential for numerous functions. Replenishing this endogenous hormone helps in the maintenance of male characteristics, muscle mass, bone density, and overall general well-being in individuals with a verified hormonal deficiency.

Regulatory References

  1. WHO Essential Medicines List
  2. Testosterone on EML

What side effects are possible with Sustenon (Testosterone)?

Possible Side Effects and Safety Information

Official regulatory safety documents for Sustenon (Testosterone) establish a profile organized by systemic effects, serious risks, and specific contraindications. Patients must be aware of the range of possible adverse effects and limitations.

Serious Safety Risks

Official warnings focus on the potential for serious cardiovascular and thromboembolic events, including stroke, myocardial infarction (heart attack), and venous thromboembolism (blood clots such as deep vein thrombosis and pulmonary embolism). There are also documented risks concerning the prostate, specifically the potential for accelerating the growth of existing prostatic carcinoma or breast carcinoma in males, which are absolute contraindications for use.

Common and System-Organ Class Adverse Reactions

The safety profile includes adverse reactions classified by frequency and affected body system. Very Common documented effects include polycythaemia (increase in red blood cells), which often necessitates monitoring of hematocrit, and acne. Common effects include increased PSA (prostate-specific antigen), benign prostatic hyperplasia symptoms, headache, increased blood pressure, weight gain, sleep apnoea, and various injection site reactions.

Contraindications and Restrictions

The medicine is contraindicated in patients with known or suspected prostatic or breast cancer. It is not recommended for use in pregnant or breastfeeding women due to the high risk of masculinization of the fetus or infant. Specific caution is required for patients with severe cardiac, hepatic, or renal insufficiency, as testosterone may cause fluid retention and may worsen these conditions.

Overdose and Emergency Response

The official regulatory profile for Sustanon (Testosterone) primarily addresses the consequences of chronic hormonal excess rather than acute, single-event overdose, which is considered unlikely due to professional administration. Documented clinical manifestations of chronic overexposure include signs like priapism (a prolonged, painful erection) and polycythaemia, an abnormal increase in red blood cells. Other documented signs of excess are fluid retention (oedema) and changes in mood, such as aggression or hostility, often linked to supra-therapeutic use.

In the event that symptoms of chronic overexposure occur, the official regulatory action required is the discontinuation of the injection until the clinical signs resolve, followed by cautious re-initiation at a lower dose. Management is described as symptomatic and supportive treatment, as no specific antidote is known to be available. Furthermore, the label requires the mandatory monitoring of hematocrit and haemoglobin levels to detect and manage polycythaemia.

Immediate medical help must be sought for the emergence of any severe manifestations. These help-seeking triggers include the development of a prolonged and painful erection, as well as symptoms indicative of severe systemic events, such as chest pain, sudden difficulty breathing, or signs of liver compromise like yellowing of the skin or eyes. Regulatory warnings highlight that high-dose exposure or misuse carries the risk of life-threatening outcomes, including myocardial infarction, stroke, and hepatic injury.

Therapeutic Uses of Sustenon (Testosterone)

Sustenon, a formulation containing the male hormone testosterone, is a medication used in adult males as testosterone replacement therapy. Its primary function is to treat various health concerns caused by a confirmed testosterone deficiency in the body, a condition often referred to as male hypogonadism.


Quick Facts: Sustenon Treatment

  • Target Condition: Confirmed testosterone deficiency (male hypogonadism).
  • Therapeutic Benefits: Aims to replace the deficient hormone to improve related symptoms.

Use of this therapy is intended to restore adequate testosterone levels. Replenishment of this hormone may help improve clinical symptoms associated with the deficiency, such as a low sex drive, fatigue, and depressive moods. The therapy may also be indicated for the treatment of bone loss (osteoporosis) resulting from a lack of androgens. Additionally, it may be used as supportive therapy for female-to-male transitioning.

Eligibility and Restrictions for Use

The eligibility for Sustenon, a testosterone ester combination, is strictly defined by government regulatory documents. It is permitted only for adult males with confirmed hypogonadism (testosterone deficiency) verified by clinical and laboratory tests. Use to boost testosterone levels in otherwise healthy older men is not an authorized use in the European Union.


Contraindicated Populations and Conditions

Sustenon must not be used in several populations and conditions, as officially labeled:

  • Cancer Status: Males with known or suspected prostate carcinoma or male breast carcinoma.
  • Excipient Allergy: Patients with known hypersensitivity to the active substance or to excipients, including Arachis oil (peanut oil) or soya.
  • Organ Failure: Patients with severe cardiac, hepatic, or renal insufficiency, or those with hypercalcaemia associated with malignant tumours.
  • Reproductive Status: The medicine is contraindicated in pregnant or breastfeeding women.

Age-Related and Conditional Use

  • Pediatric Use: Safety and efficacy are not established in males under 18 years for hypogonadism. Use in children under 3 years is contraindicated due to an excipient.
  • Restricted Use: Caution and close monitoring are required for older males, and for patients with pre-existing conditions like hypertension, epilepsy, migraine, or sleep apnoea, due to the potential for fluid retention or exacerbation of the condition.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes official interaction patterns documented in government regulatory sources. Co-administration of Sustenon (testosterone) with certain medicinal products can alter the exposure of either drug or reinforce physiological effects.

Pharmacokinetic and Pharmacodynamic Interactions

Co-administration with enzyme inducing agents may lead to a decrease in testosterone plasma levels, while enzyme inhibiting drugs may cause an increase in exposure. This modification of drug levels is a formal pharmacokinetic interaction.

Regulatory documents also detail pharmacodynamic interactions involving:

  • Oral Anticoagulants: Testosterone may enhance the anti-coagulant action of coumarin-type agents, such as Warfarin. This outcome necessitates close monitoring of Prothrombin Time and International Normalized Ratio (INR).
  • Anti-diabetic Medicines: Testosterone can improve glucose tolerance, which may decrease the requirements for insulin or other anti-diabetic medications.
  • Corticosteroids or ACTH: Concurrent use may enhance oedema formation (fluid retention). This interaction includes a specific regulatory caution for patients with existing cardiac, hepatic, or renal disease.
  • Cyclosporins: Sustenon may potentiate the effects of Cyclosporins and increase the risk of nephrotoxicity.

There are no mandatory timing-based separation rules or specific interactions with food, alcohol, or herbal products explicitly documented in the official labeling for this injectable formulation.

Mechanism of Action

Sustenon, a blend of testosterone esters, elevates plasma testosterone concentrations following cleavage of the ester moieties. The resulting free testosterone is a non-selective agonist of the Androgen Receptor ( AR), a ligand-activated transcription factor located in the cytoplasm of target cells.

Testosterone enters the cell and can be reduced by 5alpha-reductase to the more potent androgen, dihydrotestosterone ( DHT). Both T and DHT bind the AR, causing a conformational change that promotes its dissociation from heat shock proteins and subsequent translocation into the nucleus. Within the nucleus, the hormone-receptor complex binds to specific Androgen Response Elements ( AREs) on the DNA. This binding modifies the transcriptional activity of target genes, inducing the synthesis of specific proteins.

Furthermore, a fraction of T is peripherally converted to estradiol ( E2) by the enzyme aromatase. E2 acts as an agonist at the Estrogen Receptor ( ER), leading to further genomic and non-genomic signaling cascades. The resulting system-level modulation involves changes in muscle protein synthesis, adipose tissue distribution, bone mineral density, and feedback suppression of the hypothalamic-pituitary-gonadal ( HPG) axis.

Dosage and Administration Information

Sustenon (testosterone esters) is an oil-based solution intended for deep intramuscular injection only, typically into the buttock, upper leg, or upper arm. Administration should be performed exclusively by a doctor or nurse to ensure proper technique and monitoring, reducing the risk of adverse events like pulmonary oil microembolism (POME).

Dosage and Frequency

Treatment initiation and overall dosing are determined by a specialist based on the individual's condition and monitored blood testosterone levels.

Standard Dose Administration Site Frequency
1 mL (250 mg) Deep Intramuscular Injection (e.g., gluteal muscle) Usually every three weeks

Monitoring and Precautions

  • Blood Monitoring: Regular blood tests are required to monitor testosterone levels and ensure they remain within the therapeutic range (eugonadal levels). The prescribing physician will use these results to adjust the dose or the interval between injections. Monitoring of hematocrit and hemoglobin is also conducted to detect polycythemia.
  • Prostate Health: Before and during treatment, prostate-specific antigen (PSA) levels and digital rectal examinations (DRE) are necessary to exclude or monitor pre-existing prostate conditions.
  • Missed Dose: If a scheduled injection is missed, contact your healthcare provider immediately for instruction. A double dose must not be administered to compensate for a missed injection.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sustenon (Testosterone)

Research into testosterone replacement primarily involves Randomized Controlled Trials (RCTs) and Meta-analyses conducted on adult men with confirmed primary or secondary hypogonadism. These studies were designed to monitor the achievement of testosterone levels within the physiological range and examine changes in sexual function and body composition (Lean Body Mass). Findings for subjective outcomes like mood and depressive symptoms were mixed, and certainty remains uncertain across different studies.

Evidence for Musculoskeletal Outcomes also exists, with studies monitoring changes in Bone Mineral Density (BMD) and muscle strength. However, there is limited information for long-term outcomes on critical structural endpoints, such as the actual reduction of fracture risk.

Follow-up durations in many trials were limited, meaning long-term effects are not fully established for the sustainability of symptomatic relief. Research indicates that results apply only to the populations studied, and data for groups like older adults (over 65 years) remain insufficient.

Regarding the Long-Term Cardiovascular Profile, large-scale Post-marketing Safety Trials were implemented by regulators to examine the potential association with Major Adverse Cardiovascular Events (MACE). Data are still emerging from these trials, and regulatory bodies note that the evidence regarding a definitive long-term association with cardiovascular outcomes is currently inconclusive and low on certainty. Comparative evidence is lacking for many outcomes against other testosterone preparations.

Key Studies & References

  1. Testosterone replacement therapy for men with hypogonadism: A systematic review and meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Sustenon (Testosterone) (FAQ)


Q: What is the main difference between Sustenon and other forms of testosterone like Cypionate or Enanthate?

The primary difference lies in the formulation. Sustenon is a blend of four different testosterone esters, whereas medicines like Cypionate and Enanthate typically contain only a single ester. This blend is intended to provide a unique duration of effect, lasting for up to three weeks.

Q: Why does Sustenon contain four different types of testosterone?

Sustenon is formulated as a combination of four distinct testosterone compounds, known as esters. This blend is designed to achieve two effects: a rapid increase in testosterone levels shortly after injection, followed by a prolonged, steady release that is intended to maintain therapeutic levels for up to three weeks.

Q: What specific conditions is Sustenon officially approved to treat?

Sustenon is officially indicated for testosterone replacement therapy in adult males. This therapy is used to address conditions related to testosterone deficiency, also called primary and secondary hypogonadism, which must be confirmed through both clinical evaluation and biochemical tests.

Q: Is Sustenon used to help build muscle mass in general, or only for medical reasons?

Regulatory documents indicate the medicine is approved for testosterone replacement therapy. Official regulatory documentation specifically advises against the misuse of androgens to enhance athletic ability, noting that such use carries serious health risks.

Q: What are the most common side effects reported with Sustenon use?

Official product information lists a number of common side effects. These include an increase in red blood cell count, weight gain, acne, and experiencing pain at the injection site.

Q: Does using Sustenon cause mood swings, anxiety, or irritability?

Yes, official safety information lists several psychological and mood-related changes as possible side effects. These may include feelings of depression, nervousness, aggression, and general mood alterations.

Q: Is hair loss a common side effect of Sustenon injection?

Official product information lists alopecia, the medical term for hair loss or thinning, as a possible side effect of the medicine.

Q: How does Sustenon affect fertility or sperm count in men?

Testosterone treatment may lead to fertility disorders because it suppresses the natural process of sperm formation (spermatogenesis). Official documents warn that reduced fertility is a possible effect, and in some cases, this impact may be irreversible.

Q: Can Sustenon cause breast enlargement (gynecomastia)?

Yes, gynecomastia, which is the enlargement of breast tissue in men, is listed in official product information as a possible side effect associated with the use of the medicine.

Q: What are the signs of fluid retention that can happen with Sustenon?

Testosterone treatment can sometimes lead to fluid retention, which is medically described as oedema. Official documents note that signs of this may include noticeable swelling, particularly in the ankles or feet, and an increase in overall body weight.

Q: Are there any serious or less common side effects I should know about?

Regulatory documents describe a range of serious or less common effects. These include the potential growth of an undetected prostate cancer, formation of blood clots (such as deep vein thrombosis or pulmonary embolism), and a prolonged, painful erection known as priapism.

Q: Can taking Sustenon affect cholesterol or liver function test results?

Yes, regulatory documents indicate that the medicine can cause changes to cholesterol levels (lipid metabolism). It is also listed as possibly causing changes in liver function test results.

Q: Is there a known interaction between Sustenon and blood-thinning medicines (anticoagulants)?

Official warnings state that testosterone may increase the activity of coumarin-type anticoagulants (commonly called blood-thinning medicines). Co-administration may require adjustment of the anticoagulant medicine.

Q: Does Sustenon have known interactions with medicines used for diabetes?

The medicine may improve how the body processes sugar (glucose tolerance) in people with diabetes. Regulatory sources indicate that this effect may potentially lead to a decreased need for insulin or other anti-diabetic medicines.

Q: Is it possible to become dependent on Sustenon or experience withdrawal symptoms if stopped?

Testosterone is classified as a controlled substance in some regions, which reflects a potential for dependence or misuse, particularly when used outside of prescribed medical guidance. Official labels note that testosterone has been subject to abuse.

Q: Is it true that Sustenon may worsen pre-existing conditions like sleep apnea or migraine?

Official warnings recommend that the medicine be used with caution in patients with a history of certain conditions. These conditions include sleep apnoea (which may be worsened), epilepsy, migraine, and heart, liver, or kidney problems.

Q: What are the ingredients in Sustenon injection besides the testosterone esters?

The injection contains inactive ingredients, called excipients. These include arachis oil (which is peanut oil) and benzyl alcohol.

Q: Why is Sustenon contraindicated for people with a peanut or soy allergy?

Sustenon contains arachis oil (peanut oil) as an excipient. Due to the possibility of cross-sensitivity, the medicine is officially contraindicated (must not be used) in patients who are allergic to peanuts or soya.

Q: Can women use Sustenon, and what are the possible effects?

Sustenon is not indicated or approved for treatment in women. Its use may induce signs of virilisation, which is the development of male characteristics such as acne, changes in hair growth, and a deepening of the voice. Voice changes may be permanent.

Q: What is the official information regarding the use of Sustenon during pregnancy or breastfeeding?

The medicine is contraindicated and must not be used by women who are pregnant or breastfeeding. This is because official documents cite a risk of virilization (masculinization) of the foetus.

Q: Does Sustenon affect the size of the testicles or testes?

Official product information lists a reduction in the size of the testes as a possible side effect associated with the use of the medicine.

Q: What is the difference between endogenous and exogenous testosterone in the context of this medicine?

The term endogenous refers to the testosterone that the body produces naturally. Exogenous refers to the testosterone that is administered to the body through the medicine, such as the injection of Sustenon.

Q: What is the clinical goal for testosterone levels when using Sustenon?

The official goal of treatment, as described in regulatory documents, is to maintain the body's testosterone concentration within the eugonadal range. This refers to the normal levels of testosterone typically observed in healthy adult males.

Q: How does Sustenon affect the body's own natural production of testosterone?

The administration of external testosterone, such as Sustenon, signals the body to reduce its own output. This process can lead to the suppression of the body's natural (endogenous) testosterone production because the external supply provides a sufficient concentration.

Q: Is there an increase in risk for heart or cardiovascular problems associated with Sustenon?

Regulatory documents state that the medicine should be used cautiously in patients with pre-existing heart conditions. Testosterone use has been associated with an increased risk of blood clots and may cause complications, including fluid retention and the worsening of congestive cardiac failure.

Q: Does Sustenon cause a noticeable change in energy levels or libido?

Changes in sexual desire (libido) are listed in official product information as a possible side effect. These changes may involve either an increase or a decrease in libido.

Q: Is the injection site pain a common experience with Sustenon?

Yes, official safety information lists pain at the site of the injection as a common side effect of the medicine.

Q: Are there specific safety warnings for elderly patients using Sustenon?

Elderly patients require close monitoring for conditions like benign prostatic hypertrophy (prostate enlargement). Official documents also note that there is a need for careful monitoring due to potential increased risk of cardiovascular events or prostate cancer in this age group.

Q: Why do some people report acne or oily skin when using Sustenon?

Acne is explicitly listed in official product information as a common side effect of the medicine.

Q: Can Sustenon cause changes in voice (deepening) in women or adolescents?

Yes, in women and pre-pubertal boys, testosterone treatment may cause virilization (masculinization). This can include a hoarseness or deepening of the voice. Regulatory documents warn that these voice changes may be irreversible.

Q: Does Sustenon have to be stored in a specific way, like in the refrigerator?

Official storage instructions typically advise to store the medicine in its outer carton to protect it from light. It should generally not be stored above 25°C or 30°C, and refrigeration is not usually required.

Q: How long does the effect of one Sustenon injection typically last compared to other testosterone types?

Due to its specific combination of testosterone esters, a single injection of Sustenon is designed to deliver and maintain therapeutic levels of testosterone in the body for a duration of up to three weeks.

Q: What does the research say about the long-term safety of using Sustenon for a long period?

Official documents note that there is limited long-term safety data in certain patient populations, specifically regarding the potential for cardiovascular disease and prostate cancer risk over many years of treatment. Regular, long-term monitoring of prostate, blood, and lipid parameters is described in official recommendations.

Q: Are there known symptoms of using too much Sustenon (overdose) that are described in official documents?

Symptoms of an overdose are officially described as androgen-associated adverse reactions. These are effects commonly associated with male hormones, such as increased frequency of erections or fluid retention, and usually stop if the treatment is temporarily discontinued.

Q: Is it true that Sustenon contains an alcohol component like benzyl alcohol?

Yes, official product information lists benzyl alcohol as an excipient (inactive ingredient) contained within the injection solution.

Q: Can Sustenon be used if someone has a history of kidney or liver disease?

Patients with severe hepatic (liver), renal (kidney), or cardiac (heart) insufficiency are advised to be monitored closely. Official warnings note that testosterone may cause severe fluid retention (oedema) in these conditions, which can lead to complications like congestive cardiac failure.

Q: Are changes in blood sugar or glucose tolerance possible with Sustenon treatment?

Testosterone treatment may affect the way the body handles glucose (blood sugar). In patients who are also being treated for diabetes, this effect may potentially decrease the need for their anti-diabetic medications.

Q: Does Sustenon affect bone mineral density or bone strength?

Sustenon is used for testosterone replacement therapy, and official documents note that this therapy may be indicated in men who have been diagnosed with osteoporosis (weakened bones) caused by androgen deficiency.

Q: Is there a link between Sustenon use and depression or anxiety?

Official information lists depression and nervousness as possible side effects that have been observed with the use of the medicine.

Q: What information is available about Sustenon's effect on men with low libido?

Sustenon is indicated to treat the symptoms of testosterone deficiency, one of which can be low sex drive (libido). However, official safety information also lists changes to libido (either an increase or decrease) as a possible side effect.

Q: Does the official information mention any effect on sleep quality from Sustenon?

Official warnings mention that caution is advised when treating men who have sleep apnoea. There have been reports that testosterone may cause or worsen this pre-existing condition.

Q: Can Sustenon cause any changes in vision or headaches?

Official documents advise caution in patients with a history of migraine. Additionally, headaches are listed in the product information as a possible side effect of the medicine.

Q: How does the concentration of the Sustenon injection affect the treatment schedule?

The standard injection contains 250 mg of the medicine, and the dose is adjusted based on a patient's individual response and blood tests. The blend of esters means that, for replacement therapy, the usual injection frequency is approximately one injection every three weeks.

Q: Are there special considerations for patients with high blood pressure who use Sustenon?

Patients with pre-existing hypertension (high blood pressure) are advised to be monitored closely during treatment. Official documents indicate that testosterone may cause a rise in blood pressure.

How should Sustenon (Testosterone) be stored and disposed of?

Official Storage Requirements

The storage of Sustenon injection is strictly defined by regulatory guidelines to maintain its stability as an oily solution. It must be stored below 30 C and should never be placed in a refrigerator or freezer. Freezing or cooling is prohibited because it can make the oily solution highly viscous, which affects the ability to administer the injection.

The product must be stored in its original box to protect it from light and must always be kept out of the sight and reach of children.

Stability and Disposal Rules

Sustanon should not be used after the expiry date printed on the carton. Once an ampoule is opened, the solution must be used immediately, and any unused portion must be properly discarded.

For disposal, the medicine should not be placed in household trash or poured down the drain. Unused or expired Sustenon must be returned to a pharmacist or designated collection point for proper pharmaceutical waste management, in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sustenon (Testosterone) found in:

A-Z Index: